Categories calculated via ROC-curve: | < 15.59 | > 15.59 | total | P-value | missing |
---|---|---|---|---|---|
Ranges (s-TATI μg/l) | 4.346-15.587 | 15.588-168.570 | |||
n(%) | 192(59.3) | 132(40.7) | 324(100) | ||
Age | |||||
< 75 | 129(69.7) | 50(40.7) | 179(58.1) | ||
≥75 | 56(30.3) | 73(59.3) | 129(41.9) | < 0.001** | 16(4.9) |
Gender | |||||
Female | 90(46.9) | 71(53.8) | 161(49.7) | ||
Male | 102(53.1) | 61(46.2) | 163(50.3) | 0.289 | 0(0.0) |
Disease stage | |||||
I | 26(13.7) | 18(13.8) | 44(13.8) | ||
II | 84(44.2) | 50(38.5) | 134(41.9) | ||
III | 58(30.5) | 37(28.5) | 95(29.7) | ||
IV | 22(11.6) | 25(19.2) | 47(14.7) | 0.284 | 4(1.2) |
Differentiation grade | |||||
High-moderate | 155(80.7) | 95(74.2) | 250(78.1) | ||
Poor | 37(19.3) | 33(25.8) | 70(21.9) | 0.168 | 4(1.2) |
Vascular invasion | |||||
No invasion | 164(88.6) | 106(86.2) | 270(87.7) | ||
Invasion | 21(11.4) | 17(13.8) | 38(12.3) | 0.519 | 16(4.9) |
Mucinous or non-mucinous | |||||
Non mucinous tumour | 161(87.0) | 106(86.2) | 267(86.7) | ||
Mucinous tumour | 24(13.0) | 17(13.8) | 41(13.3) | 0.830 | 16(4.9) |
Colon or rectal cancer | |||||
Colon cancer | 115(59.6) | 102(77.9) | 217(67.0) | ||
Rectal cancer | 78(40.4) | 29(22.1) | 107(33.0) | 0.001 | 0(0) |
Colon left or right ex ca recti | |||||
Right colon | 58(50.4) | 64(63.4) | 122(56.2) | ||
Left colon | 57(49.6) | 37(36.6) | 94(43.5) | 0.056 | 1(0.5) |
CEA serum | |||||
< 2,67 μg/L | 101(52.6) | 57(43.2) | 158(48.8) | ||
≥ 2,67 μg/L | 91(47.4) | 75(56.8) | 166(51.2) | 0.095 | 0(0) |
Preop radiation therapy | |||||
Received | 129(66.8) | 110(84.0) | 239(73.8) | ||
Not received | 64(33.2) | 21(16.0) | 85(26.2) | 0.001 | 0(0) |
TATI expression in tissue | |||||
< 50% | 145(81.0) | 87(73.7) | 232(78.1) | ||
≥ 50% | 34(19.0) | 31(26.3) | 65(21.9) | 0.138 | 27(8.3) |